JP2018537076A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018537076A5 JP2018537076A5 JP2018520493A JP2018520493A JP2018537076A5 JP 2018537076 A5 JP2018537076 A5 JP 2018537076A5 JP 2018520493 A JP2018520493 A JP 2018520493A JP 2018520493 A JP2018520493 A JP 2018520493A JP 2018537076 A5 JP2018537076 A5 JP 2018537076A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- nucleic acid
- isolated nucleic
- catalytic
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562245978P | 2015-10-23 | 2015-10-23 | |
| US62/245,978 | 2015-10-23 | ||
| US201662382691P | 2016-09-01 | 2016-09-01 | |
| US62/382,691 | 2016-09-01 | ||
| PCT/US2016/058429 WO2017070654A1 (en) | 2015-10-23 | 2016-10-24 | Programmable universal cell receptors and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018537076A JP2018537076A (ja) | 2018-12-20 |
| JP2018537076A5 true JP2018537076A5 (https=) | 2019-09-19 |
Family
ID=58558187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018520493A Pending JP2018537076A (ja) | 2015-10-23 | 2016-10-24 | プログラム可能な普遍的細胞受容体およびその使用法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20170112878A1 (https=) |
| EP (1) | EP3365016A4 (https=) |
| JP (1) | JP2018537076A (https=) |
| KR (1) | KR20180091820A (https=) |
| CN (1) | CN108883170A (https=) |
| AU (1) | AU2016341321A1 (https=) |
| CA (1) | CA3002774A1 (https=) |
| EA (1) | EA201890941A1 (https=) |
| TW (1) | TW201726914A (https=) |
| UY (1) | UY36961A (https=) |
| WO (1) | WO2017070654A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017070654A1 (en) * | 2015-10-23 | 2017-04-27 | Sorrento Therapeutics, Inc. | Programmable universal cell receptors and methods of using the same |
| EP3448987A4 (en) | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| WO2019010201A1 (en) * | 2017-07-03 | 2019-01-10 | Yale University | REGULATED SMALL MOLECULE ADAPTER |
| CA3080109A1 (en) * | 2017-11-03 | 2019-05-09 | Sorrento Therapeutics, Inc. | Cd38-directed chimeric antigen receptor constructs |
| SG11202008568WA (en) * | 2018-03-09 | 2020-10-29 | Sorrento Therapeutics Inc | Dimeric antigen receptors (dar) |
| WO2021080846A1 (en) * | 2019-10-23 | 2021-04-29 | The Scripps Research Institute | Novel conjugation chemistry for catalytic anttibody 38c2 |
| EP4114415A1 (en) * | 2020-03-06 | 2023-01-11 | Sorrento Therapeutics, Inc. | Innate immunity killer cells targeting psma positive tumor cells |
| WO2022081486A1 (en) * | 2020-10-12 | 2022-04-21 | Sorrento Therapeutics, Inc. | Cd19-directed chimeric antigen receptor constructs |
| EP4274852A4 (en) * | 2021-01-11 | 2025-02-26 | Eutilex Co., Ltd. | BISPECIFIC EPITOP-BINDING PROTEIN WITH ANTI-4-1BB ANTIBODY AND PD-1 PROTEIN OR FRAGMENTS THEREOF AND USE THEREOF |
| WO2022226364A2 (en) * | 2021-04-23 | 2022-10-27 | Sorrento Therapeutics, Inc. | Dimeric antigen receptors (dars) that bind gd2 |
| US20250186494A1 (en) * | 2022-02-10 | 2025-06-12 | The Scripps Research Institute | Car-t therapies targeted via covalently bonded adapters |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6268488B1 (en) * | 1999-05-25 | 2001-07-31 | Barbas, Iii Carlos F. | Prodrug activation using catalytic antibodies |
| AU2004210088A1 (en) * | 2003-02-06 | 2004-08-19 | Micromet Ag | Trimeric polypeptide construct to induce an enduring T cell response |
| EP4464384A3 (en) * | 2007-08-17 | 2025-01-08 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| US8465743B2 (en) * | 2009-10-01 | 2013-06-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| WO2012007896A1 (en) * | 2010-07-12 | 2012-01-19 | Covx Technologies Ireland, Ltd. | Multifunctional antibody conjugates |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| EP2694549B1 (en) * | 2011-04-08 | 2018-08-15 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer |
| US9708384B2 (en) * | 2011-09-22 | 2017-07-18 | The Trustees Of The University Of Pennsylvania | Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens |
| US10851178B2 (en) * | 2011-10-10 | 2020-12-01 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
| WO2017070654A1 (en) * | 2015-10-23 | 2017-04-27 | Sorrento Therapeutics, Inc. | Programmable universal cell receptors and methods of using the same |
-
2016
- 2016-10-24 WO PCT/US2016/058429 patent/WO2017070654A1/en not_active Ceased
- 2016-10-24 EA EA201890941A patent/EA201890941A1/ru unknown
- 2016-10-24 US US15/333,115 patent/US20170112878A1/en not_active Abandoned
- 2016-10-24 TW TW105134363A patent/TW201726914A/zh unknown
- 2016-10-24 CN CN201680076271.2A patent/CN108883170A/zh active Pending
- 2016-10-24 KR KR1020187014623A patent/KR20180091820A/ko not_active Withdrawn
- 2016-10-24 JP JP2018520493A patent/JP2018537076A/ja active Pending
- 2016-10-24 UY UY0001036961A patent/UY36961A/es not_active Application Discontinuation
- 2016-10-24 AU AU2016341321A patent/AU2016341321A1/en not_active Abandoned
- 2016-10-24 EP EP16858424.1A patent/EP3365016A4/en not_active Withdrawn
- 2016-10-24 CA CA3002774A patent/CA3002774A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018537076A5 (https=) | ||
| JP7291196B2 (ja) | 抗ヒトパピローマウイルス１６ ｅ７ ｔ細胞受容体 | |
| JP6633081B2 (ja) | 細胞 | |
| JP7303314B2 (ja) | Ｇｐｒｃ５ｄキメラ抗原受容体及びそれを発現する細胞 | |
| JP7179030B2 (ja) | Ｒｏｒ１ ｃａｒ ｔ細胞 | |
| JP2022109915A (ja) | Ｃｄ８０バリアント免疫調節タンパク質およびその使用 | |
| JP7313746B2 (ja) | キメラ抗原受容体及び当該キメラ抗原受容体を発現する免疫エフェクター細胞 | |
| KR20200015713A (ko) | 항-trbc1 항원 결합 도메인 | |
| JP2015513920A5 (https=) | ||
| JP7584453B2 (ja) | Ｔａｃｉを標的とする抗体及びキメラ抗原受容体 | |
| EP3773630A1 (en) | Bcma-car-t cells | |
| CN114401989A (zh) | 靶向bcma的抗体及嵌合抗原受体 | |
| CN110461363B (zh) | 靶向cd37的嵌合抗原受体 | |
| JP2020532969A5 (https=) | ||
| US20250236864A1 (en) | CAR LIBRARY AND scFv MANUFACTURING METHOD | |
| US20210079111A1 (en) | Cd19-cd20 bispecific and dual passway car-t and methods for use thereof | |
| WO2024210072A1 (ja) | キメラタンパク質、核酸、ベクター、ｔ細胞又はｎｋ細胞、医薬組成物、組み合わせ物、組み合わせ医薬、及び標的抗原結合タンパク質 | |
| CN118541394A (zh) | 分泌team的抗间皮素car t细胞及其使用方法 | |
| JPWO2022104424A5 (https=) | ||
| Angyal et al. | Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases |